This Prostate Cancer Awareness Month, National Nonprofit Urges Early Detection as Key to Survival September 9, 2022 FOR IMMEDIATE RELEASEMedia Contact:Stephanie S. JohnsonZERO Prostate Cancerstephjohnson@zerocancer.org | media@zerocancer.org(202) 998-2507 MEDIA ADVISORYExperts from ZERO Prostate Cancer Available for Timely and Important Interviews this SeptemberINVITE: You’re invited to partake in a special and timely virtual media tour this fall.OCCASION: September marks Prostate Cancer Awareness Month. All month long, the nation’s leading nonprofit in the fight against prostate cancer, ZERO Prostate Cancer, will partner with experts and celebrity spokespersons to raise awareness for the importance of early detection. When caught in early stages, prostate cancer has a survival rate of 98%. But when caught late, the survival rate falls to a much less hopeful 31%. ZERO is encouraging all men to learn about prostate cancer risks and promote early detection during Prostate Cancer Awareness Month (PCAM), beginning September 1. Highlights include 22 nationwide ZERO Prostate Cancer Run/Walks, celebrity collaborations, podcast releases, and details surrounding ZERO’s 2023 Summit.EXPERTS AVAILABLE FOR INTERVIEW: Jamie Bearse, CEO and President of ZERO Prostate Cancer [Boston, MA]; Tony Minter, Prostate Cancer Survivor [Columbia, SC]WHEN: Tuesday, September 13, 2022; 10:45 a.m. – 12:30 p.m. ET {10 minute windows available for booking}WHERE: Interviews can be conducted remotely via Zoom.WHY: Over 3 million men are living with prostate cancer, making it the most commonly diagnosed cancer among American men. Every 15 minutes another American man dies from prostate cancer. That’s more than 94 deaths per day and 34,500 this year. Black men are almost twice as likely to be diagnosed with prostate cancer and over twice as likely to die from prostate cancer as White men. HOW: For interviews or additional information, please contact Jessica Fetrow, Media Coordinator. About ZERO Prostate CancerZERO Prostate Cancer (ZERO) is on a mission to improve and save lives from prostate cancer through advocacy, education, awareness, and support. Formerly known as the National Prostate Cancer Coalition, ZERO was founded in 1996 to stand up for people impacted by prostate cancer. Today, ZERO serves as the nation's leading prostate cancer organization, advancing a future where prostate cancer detection is early, support is unwavering, and care is accessible to all. For over 30 years, ZERO has led the way in prostate cancer advocacy, screenings, and partnerships, successfully unlocking funding toward breakthrough discoveries, treatments, and lifesaving access to care. As the nation’s #1 provider of prostate cancer resources, programs, and services, ZERO has supported millions of people at-risk or diagnosed, and their families. As the voice of the prostate cancer community, ZERO's urgent focus on breaking barriers to survival—by closing gaps in diagnosis, treatment, and care—brings critical attention to those most likely to be impacted by this disease. Learn more at ZEROcancer.org About Prostate Cancer Advocacy Press Release Screening & PSA Test Spreading Awareness More for you
This Prostate Cancer Awareness Month, National Nonprofit Urges Early Detection as Key to Survival September 9, 2022
FOR IMMEDIATE RELEASEMedia Contact:Stephanie S. JohnsonZERO Prostate Cancerstephjohnson@zerocancer.org | media@zerocancer.org(202) 998-2507
MEDIA ADVISORYExperts from ZERO Prostate Cancer Available for Timely and Important Interviews this SeptemberINVITE: You’re invited to partake in a special and timely virtual media tour this fall.OCCASION: September marks Prostate Cancer Awareness Month. All month long, the nation’s leading nonprofit in the fight against prostate cancer, ZERO Prostate Cancer, will partner with experts and celebrity spokespersons to raise awareness for the importance of early detection. When caught in early stages, prostate cancer has a survival rate of 98%. But when caught late, the survival rate falls to a much less hopeful 31%. ZERO is encouraging all men to learn about prostate cancer risks and promote early detection during Prostate Cancer Awareness Month (PCAM), beginning September 1. Highlights include 22 nationwide ZERO Prostate Cancer Run/Walks, celebrity collaborations, podcast releases, and details surrounding ZERO’s 2023 Summit.EXPERTS AVAILABLE FOR INTERVIEW: Jamie Bearse, CEO and President of ZERO Prostate Cancer [Boston, MA]; Tony Minter, Prostate Cancer Survivor [Columbia, SC]WHEN: Tuesday, September 13, 2022; 10:45 a.m. – 12:30 p.m. ET {10 minute windows available for booking}WHERE: Interviews can be conducted remotely via Zoom.WHY: Over 3 million men are living with prostate cancer, making it the most commonly diagnosed cancer among American men. Every 15 minutes another American man dies from prostate cancer. That’s more than 94 deaths per day and 34,500 this year. Black men are almost twice as likely to be diagnosed with prostate cancer and over twice as likely to die from prostate cancer as White men. HOW: For interviews or additional information, please contact Jessica Fetrow, Media Coordinator.
About ZERO Prostate CancerZERO Prostate Cancer (ZERO) is on a mission to improve and save lives from prostate cancer through advocacy, education, awareness, and support. Formerly known as the National Prostate Cancer Coalition, ZERO was founded in 1996 to stand up for people impacted by prostate cancer. Today, ZERO serves as the nation's leading prostate cancer organization, advancing a future where prostate cancer detection is early, support is unwavering, and care is accessible to all. For over 30 years, ZERO has led the way in prostate cancer advocacy, screenings, and partnerships, successfully unlocking funding toward breakthrough discoveries, treatments, and lifesaving access to care. As the nation’s #1 provider of prostate cancer resources, programs, and services, ZERO has supported millions of people at-risk or diagnosed, and their families. As the voice of the prostate cancer community, ZERO's urgent focus on breaking barriers to survival—by closing gaps in diagnosis, treatment, and care—brings critical attention to those most likely to be impacted by this disease. Learn more at ZEROcancer.org
